By Finance Pulse in KeyInfo —

Brookline Rates Medicus Pharma as Buy with $12 Target

Brookline Capital initiates coverage of Medicus Pharma, assigning a Buy rating and targeting $12, highlighting its innovative skin patch technology.

A sleek and modern design featuring a futuristic skin patch, set against a backdrop of dynamic finan
Brookline Rates Medicus Pharma as Buy with $12 Target

Brookline initiated coverage of Medicus Pharma (MDCX) with a Buy rating and $12 price target, focused on its innovative skin patch.

Source